Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
about
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathwayMetabolic rewiring in mutant Kras lung cancer.Exploring gold nanoparticle interactions with proteins and the tumor microenvironment in biological systems.Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies.Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics.The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.TUMOR CROSSTALK NETWORKS PROMOTE GROWTH AND SUPPORT IMMUNE EVASION IN PANCREATIC CANCER.Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer.Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness.Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma.Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future OptionsWe're Not "DON" Yet: Optimal Dosing and Prodrug Delivery ofLAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
P2860
Q33906161-47EE2B53-F11D-43D4-8ACC-FA15BE33BEA4Q39343660-BD0F7D08-26AB-400F-BE4A-0FA1C8F739A2Q40963650-256CA365-8EC7-46F7-A26B-5B377D9CE4B6Q42154484-B75F79AA-1E31-4701-81A2-C7134DAB8141Q46876969-FEDDFA3B-F1E2-4E48-8DE0-C32F0169AEEEQ48099236-529BB307-74C1-4A44-B051-CE8072FD826CQ49167162-AE10EB15-1F16-4C80-9620-2126D845717FQ49843616-09CBCEDD-00FF-4D6D-8E81-07FF95FFCA2AQ52354472-D1B40EE7-58E0-447C-8B33-BED3A7A33BE6Q52431407-299EC75C-4C46-4255-AFCE-33CB13B697E9Q52739894-6E4987E3-EAB8-44DA-978A-9AE50985CDD4Q53826606-496DC68E-6047-4DE6-8197-6346C7CB3A30Q55445091-8B4DC3FB-6E7E-4FD2-B766-D3304F92BA92Q56890107-96BFC072-5908-44DE-9300-86B13665215CQ57165398-96DE2D07-8A85-45B4-9EF1-01F077A76822Q59136191-44185EDD-DFB8-4D32-BA1F-3F5C742297A3
P2860
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
@en
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
@nl
type
label
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
@en
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
@nl
prefLabel
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
@en
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
@nl
P1433
P1476
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
@en
P2093
Christopher J Halbrook
P356
10.1016/J.CCELL.2016.12.006
P577
2017-01-01T00:00:00Z